- Home
- NCNA vs DPU Comparison
NCNA vs DPU Comparison
Compare NCNA & DPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.48
N/A
Current Price
$2.05
Company Overview
Basic Information| Metric | NCNA | DPU |
|---|---|---|
| Founded | 1997 | N/A |
| Country | United Kingdom | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7M | 6.8M |
| IPO Year | 2017 | 2023 |
Fundamental Metrics
Financial Performance| Metric | NCNA | DPU |
|---|---|---|
| Price | $1.48 | $2.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 36.3K | 8.5K |
| Earning Date | 06-01-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.21 | $1.62 |
| 52 Week High | $7.01 | $2.31 |
Technical Indicators
Market Signals| Indicator | NCNA | DPU |
|---|---|---|
| Relative Strength Index (RSI) | 46.95 | 32.96 |
| Support Level | $1.33 | $1.62 |
| Resistance Level | $1.41 | $2.26 |
| Average True Range (ATR) | 0.07 | 0.17 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 76.18 | 42.42 |
Price Performance
Historical Comparison NCNA
DPU
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.